Back
MARUWA CO., LTD. Vs. Novo Nordisk A/S Sector Stock Comparison
Buy
57
MAWAF
MARUWA CO., LTD.
Last Price:
$274.00
Seasonality Move:
0%
Sell
22
NVO
Novo Nordisk A/S
Last Price:
$47.69
Seasonality Move:
4.04%
Buy
57
MARUWA CO., LTD. (MAWAF)
is a Buy
Is MARUWA CO., LTD. a Buy, Sell or Hold?
-
The current MARUWA CO., LTD. [MAWAF] share price is $274.00. The Score for MAWAF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
MAWAF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $47.77. The Score for NVO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MAWAF Stock Price Chart
What is MARUWA CO., LTD.'s stock price today?
-
The MARUWA CO., LTD. share price today is $274.00The current trend is relatively stagnant and MAWAF is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $47.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
MAWAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.19 | Buy |
| Relative Strength Index (14 RSI): | 73.4 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (274 - 274) | Sell |
| Bollinger Bands (100): | (204.64 - 299.86) | Buy |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 45.38 | Sell |
| Chaikin Money Flow: | -9529843 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47 - 49.56) | Sell |
| Bollinger Bands (100): | (48.26 - 56.98) | Sell |
MAWAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 274 | Sell |
| 20-day SMA: | 274 | Sell |
| 50-day SMA: | 268.71 | Buy |
| 200-day SMA: | 220.61 | Buy |
| 8-day EMA: | 273.98 | Buy |
| 20-day EMA: | 273.23 | Buy |
| 50-day EMA: | 268.15 | Buy |
| 200-day EMA: | 251.49 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.72 | Sell |
| 20-day SMA: | 48.17 | Sell |
| 50-day SMA: | 50.45 | Sell |
| 200-day SMA: | 61.29 | Sell |
| 8-day EMA: | 48.77 | Sell |
| 20-day EMA: | 48.67 | Sell |
| 50-day EMA: | 50.42 | Sell |
| 200-day EMA: | 63.4 | Sell |
MARUWA CO., LTD. Earnings Growth & MAWAF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and a decrease next year of $0.15 per share.
MARUWA CO., LTD. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||